The Food and Drug Administration will accept nominations through Dec. 11 for experts to serve on a committee that will advise the agency on issues related to digital health technologies, from artificial intelligence/machine learning and digital therapeutics to wearables and remote patient monitoring. 
 
“Many of these technologies are novel and tend to rapidly change; it’s our duty to seek as much knowledge on them as possible as we determine and implement appropriate regulation to encourage innovation while protecting public health,” said Troy Tazbaz, director of the FDA’s Digital Health Center of Excellence. 

Related News Articles

Headline
AHA President and CEO Rick Pollack was recently a guest on Pinkston's "To the Point" podcast to discuss the future of U.S. health care, touching on a range of…
Headline
The Cybersecurity and Infrastructure Security Agency, FBI and other federal agencies have created a webpage with the latest cyberthreat updates and information…
Headline
The Cybersecurity and Infrastructure Security Agency Oct. 31 issued an alert on a large-scale spear-phishing campaign targeting organizations in several…
Headline
The Health Sector Cybersecurity Coordination Center on Oct. 28 released a report on the "Miracle Exploit," a set of critical vulnerabilities affecting Oracle…
Headline
A new AHA Cyber Intel blog by John Riggi, AHA’s national advisor on cybersecurity and risk, examines current trends and challenges in health care regarding…
Chairperson's File
Cyberattacks are increasing and expected to reach record numbers in the U.S. by the end of 2024. Although no field or industry is immune from attacks that…